Publication | Closed Access

Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells

Cell TherapyCancer ImmunosurveillanceGamma Chain CytokinesT-regulatory CellImmunologyHer2/neu-specific T CellsCell BiologyAdoptive TransferImmunotherapyMedicineCell TransplantationTumor Biology